Titre : | The confidentiality of alcohol and drug abuse patient records regulation and the HIPAA privacy rule. Implications for alcohol and substance abuse programs |
Titre traduit : | (Gestion de la confidentialité des dossiers des patients alcooliques et toxicomanes et les règles de l'HIPPA - Health Insurance Portability and Accountability Act - concernant la vie privée. Implications sur les programmes alcool toxicomanie) |
Auteurs : | U.S. Department of Health and Human Services ; SAMHSA ; Center for Substance Abuse Prevention ; Center for Substance Abuse Treatment |
Type de document : | Rapport |
Editeur : | Rockville, MD : SAMHSA, 2004 |
Collection : | DHHS Publication No. (SMA) 04-3947 |
Format : | 40 p. |
Note générale : |
Rockville, MD, SAMHSA, 2004, (DHHS Publication No. (SMA) 04-3947), 40 p., Autre source de publication : http://www.hipaa.samhsa.gov/Part2ComparisonClearedTOC.htm |
Langues: | Anglais |
Discipline : | LOI (Loi et son application / Law enforcement) |
Mots-clés : |
Thésaurus mots-clés SECRET PROFESSIONNEL ; INFORMATIQUE ; PROGRAMME ; TRAITEMENT ; DEPENDANCEThésaurus géographique ETATS-UNIS |
Résumé : |
ENGLISH : For three decades, confidentiality has been a cornerstone practice for substance abuse treatment programs across the country. In December, 2000, the Department of Health and Human Services (HHS) issued the "Standards for Privacy of Individually Identifiable Health Information" final rule (Privacy Rule), pursuant to the Administrative Simplification provisions of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Substance abuse treatment programs that are subject to HIPAA must comply with the Privacy Rule.2 3 Substance abuse treatment programs that already are complying with Part 2 should not have a difficult time complying with the Privacy Rule, as it parallels the requirements of Part 2 in many areas. Programs subject to both sets of rules must comply with both, unless there is a conflict between them. Generally, this will mean that substance abuse treatment programs should continue to follow the Part 2 regulations. In some instances, programs will have to establish new policies and procedures or alter existing policies and practices. In the event a program identifies a conflict between the rules, it should notify the Substance Abuse and Mental Health Services Administration of HHS immediately for assistance in resolving the conflict. This guidance is for substance abuse treatment programs that are subject to and already complying with the confidentiality requirements of Part 2.4 It explains which programs must also comply with the Privacy Rule and outlines what compliance will rewill require. The guidance is not a legal opinion. To comply with the Privacy Rule, programs should apply this guidance to their individual situations; programs may also want to call upon State agencies, provider organizations and legal counsel for assistance in establishing and implementing the practices and policy changes required by the Privacy Rule. (Extract of the publication.) |
Domaine : | Plusieurs produits / Several products |
Affiliation : | Etats-Unis. United States. |
Numéro Toxibase : | 506227 |
Centre Emetteur : | 05 Marmottan |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil